Marksans Pharma has reported results for first quarter ended June 30, 2026 (Q1FY27).
The company has reported 43.65% jump in its net profit at Rs 69.04 crore for the quarter ended June 30, 2026 as compared to Rs 48.06 crore for the same quarter in the previous year. The total income of the company has increased by 5.26% at Rs 338.66 crore for Q1FY27 as compared to Rs 321.74 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported near three-fold jump in its net profit at Rs 157.17 crore for Q1FY27 as compared to Rs 58.32 crore for the same quarter in the previous year. The total income of the company has increased by 38.45% at Rs 866.20 crore for Q1FY27 as compared to Rs 625.63 crore for the corresponding quarter previous year.
